Immunohematology Boot Camp: Drug-Induced Immune Hemolytic Anemia (26EL-612)

Please note: AABB reserves the right to make updates to this program.

• Educational Track: Technical/Clinical
• Topics: Blood Donation & Collection, Patient Transfusion
• Intended Audience: Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists
• Teaching Level: Basic, Intermediate

• Director/Moderator: Laura Staller, MHA, MLS(ASC)^CM, Manager, Customer Ready Products, NMDP, Minneapolis, MN
  Speakers:

  • Sue T. Johnson, MSTM, MLS(ASCP)SBB^CM, Director, Clinical Education & SBB Program, Versiti Wisconsin, Milwaukee, WI
  • Maddie Konicek, MLS(ASCP)^CMSBB^CM, Senior Scientist, Immunohematology Reference Laboratory, Versiti Wisconsin, Milwaukee, WI

• Program Description

  Immune hemolytic anemia is rarely drug-induced, therefore when it is caused by a drug-dependent antibody, laboratory professionals and clinicians can struggle identifying it. This boot camp will further the participant's understanding of drug-induced immune hemolytic anemia (DIIHA), and how to identify a patient possibly experiencing this type of hemolytic anemia. Drugs known to cause DIIHA and the importance of determining timing and dosage in relation to a hemolytic event will further educate blood bankers/medical laboratory scientists and clinicians on what to look for when reviewing patient medication history.

  Learning Objectives

  After participating in this educational activity, participants should be able to:

  • Describe initial serologic findings of drug-induced immune hemolytic anemia (DIIHA).
  • Distinguish drug-dependent antibodies from warm or cold autoantibodies.
  • List the most common drugs causing DIIHA.
  • Discuss the pathophysiology of drug-induced immune hemolytic anemia.
  • Summarize the current testing methodologies available for identifying drug-dependent antibodies causing DIIHA.

  Registration

  Registration includes access to both the live and on-demand version of this eCast.

  If you are a facility interested in participating in this eCast, simply complete the Group Viewing registration form and AABB will provide detailed instructions to share with your team approximately one week prior to the live program (each team member to register for the program utilizing a promocode). For single viewers, simply click on the Register button below to register.

  Please note: registration for the live eCast will close 1 hour prior to the eCast start time. If you register after this time, you will receive access to the on-demand eCast when it is available.

  Single Viewer	Register
  Group Viewing	Register

  Continuing Education Credit

  This activity is eligible for one (1) continuing education credit/contact hour for Physicians, California Nurses, California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.

  There is no financial support for this activity.

  

  In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB), which is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

  Physicians (ACCME): AABB designates this live activity for a maximum of one (1) AMA PRA Category 1 Credit^TM. AABB designates this enduring activity for a maximum of one (1) AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  Claiming Credit
  Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.

  Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).

  Program & Credit Expiration Dates:

  • Live Activity Program Date: March 11, 2026; Credit Expiration Date: April 11, 2026
  • Enduring Activity Program Dates: March 11, 2026 – March 10, 2029; Credit Expiration Date: March 10, 2029

  Disclosure Declaration

  It is the policy of the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of its CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. AABB has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.

  Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and AABB personnel are provided at the beginning of the program.

  Faculty Biographies

  Sue Johnson, MSTM, MLS(ASCP)SBB^CM is Director of Clinical Education and the SBB program at Versiti and Director of the Transfusion Medicine Program at Marquette University and a Clinical Associate Professor at University of Wisconsin-Milwaukee, College of Health Science. Prior to this, she worked in the Immunohematology Reference Laboratory for over 25 years developing a special interest in drug-induced immune hemolytic anemia. Sue has been actively involved in AABB serving on many committees. Sue has authored numerous publications in the field of Transfusion Medicine and Immunohematology including Judd's Methods in Immunohematology and Blood Banker Favorites: A Collection of Best Recipes for Blood Sample Preparation. She has also had the honor of being an associate editor of the 20th and 21st edition of the AABB Technical Manual.

  Maddie Konicek is a Senior Scientist in the Immunohematology Reference Lab at Versiti Wisconsin. She has previously worked for Children's Wisconsin and Duke University Hospital in the Transfusion Services department before transferring to the IRL in 2013. Continuing on the path of transfusion medicine, Maddie obtained her SBB certification in 2014 and has worked on many projects within the lab including both serology and molecular based assays. Her interests include ABO sequencing and teaching MLS and SBB students in complex antibody identifications.

  Laura Staller is a Medical Laboratory Scientist overseeing Customer Ready Products at NMDP. She began her career in the immunohematology reference laboratory at Bonfils Blood Center in Denver, CO. Her strong interest in blood centers led to her St. Paul, MN, and the donor testing laboratory at Memorial Blood Centers where she oversaw a team of skilled technicians in a high-volume infectious disease laboratory. She is now focused on cellular therapies at NMDP where she collaborates with cell therapy laboratories to extend their cryopreservation and specialty processing capabilities to transplant centers and leads the operational aspects of the cord blood program. Laura holds a Master of Healthcare Administration from Ohio University.